Medical treatment of behavioural disturbances of dementia (BPSD). A limited proposal based on the effect of intervention studies;Medicamenteuze behandeling van gedrags- en psychische problemen bij dementie (BPSD): Vanuit een overzicht van effectiviteit naar een summier behandelvoorstel

Tijdschrift voor Verpleeghuisgeneeskunde

Volumn 27, Issue 5, 2003, Pages 5-9

  Dautzenberg, Paul L J ^a   Wouters, Cees ^a   De Jonghe, Jos ^b   Kalisvaart, C J ^c   Kat, M G ^c   Schols, J M G A ^d   Van Der Veer, J K ^e   Verhey, F R J ^f   Verkaaik, A J B ^d  

^a JEROEN BOSCH HOSPITAL   (Netherlands)

^b Afd Geriatrie Medisch Ctr Alkmaar   (Netherlands)

^c Medical Centre Alkmaar   (Netherlands)

^d Verpleeghuis De Riethorst ^*

^e Sinai Centrum   (Netherlands)

^f MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; CARBAMAZEPINE; CHOLINESTERASE INHIBITOR; CITALOPRAM; CLOMETHIAZOLE; CLOPENTHIXOL; DIPHENHYDRAMINE; HALOPERIDOL; LOXAPINE; MIANSERIN; MOCLOBEMIDE; OLANZAPINE; OXAZEPAM; PAROXETINE; RISPERIDONE; THIORIDAZINE; TIAPRIDE; TRAZODONE;

AGGRESSION; ALERTNESS; APATHY; ARTICLE; BEHAVIOR DISORDER; CLINICAL TRIAL; DEMENTIA; DEPRESSION; DRUG CHOICE; DRUG EFFICACY; HUMAN; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; SIDE EFFECT; TREATMENT OUTCOME;

EID: 0347124780     PISSN: 13861514     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Merriam AE, Arons MK, Gaston P, Wey SL, Katz I. The psychiatric symptoms of Alzheimer's disease. J Am Geriatr Soc 1988;36:7-12.
2. Janzing JE, Bouwens JP, Fennema HJ, Teunisse RJ, Zitman FG. De prevalentie van psychiatrische comorbiditeit by Dementie van het Alzheimer Type (DAT). Tijdschrift voor Psychiatrie 1993;38:590-601.
3. Lyketsos CG, Steele C, Galik E et al. Physical aggression in dementia patients and its relationship to depression. Am J Psychiatry 1999;156:66-71.
4. Hope T, Keen J, Fairburn CG, Jacoby R, McShane R. Natural history of behavioral changes and psychiatric symptoms in Alzheimer's disease. A longitudinal study. Br J Psychiatry 1999;174:39-44.
5. Lysketos CG, Steinberg M, Tschanz JT, Norton MC, Steffens DC, Breitner JC. Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. Am J Psychiatry 2000;157:708-14.
6. Finkel SI. Behavioral and psychological signs and symptoms of dementia: Implications for research and treatment. International Psychogeriatrics 1996;8(suppl. 3):215-552.
7. Deimling GT, Bass DM. Symptoms of mental impairment among elderly adults and their effects on family caregivers. J Gerontol 1986;41:778-84.
8. Cohen-Mansfield J. Assesessment of disruptive behavior/agitation in the elderly: function, methods and difficulties. J Geriatr Psychiatry Neurol 1995;8(suppl 1):52-60.
9. Steele C, Rovner B, Chase GA, Folstein M. Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. Am J Psychiatry 1990;147:1049-51.
10. Willekens-Bogaers MAJH, Vollaard EJ. Antipsychotica in de psychogeriatrie. Een voorstel voor een rationeler voorschrijfbeleid. Tijdschr Gerontol en Geriatr 1985;16:179-89.
11. Willekens-Bogaers MAJH, Smits GWJM. Antipsychotica in de psychogeriatrie. Evaluatie van een behandelvoorstel. Tijdschr Gerontol Geriatr 1990;21:99-107. 2000;157:4-15.
12. Willekens-Bogaers MAJH, Smits GWJM. Antipsychotica in de psychogeriatrie. Evaluatie van een behandelvoorstel. Tijdschr Gerontol Geriatr 1990;21:99-107. 2000;157:4-15.
13. Nyth AL, Gottfries CG. The clinical efficay of citalopram in treatment of emotional disturbances in dementia disorders: a Nordic multicentre study. Br J Psychiatry 1990;157:894-901.
14. Nyth AL, Gottfries CG, Lyby K et al. A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia. Acta Psychiatr Scand 1992;86:138-45.
15. Carlyle W, Ancill RJ, Sheldon L. Aggression in the demented patient: a double-blind study of loxapine versus haloperidol. International Clinical Psychopharmacology 1993;8:103-8.
16. Finkel SI, Lyons JS, Anderson RL et al. A randomized, placebo-controlled trial of thiothixene in agitated demented nursing home patients. International Journal of Geriatric Psychiatry 1995;10:129-36.
17. Roth M, Mountjoy Q, Amrein R. Moclobemide in elderly patients with cognitive decline and depression. B J Psychiatry 1996;168:149-57.
18. Petracca G, Teson A, Chemeriski E, Leiguarda R, Starkstein SE. A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease. The Journal of Neuropsychiatry and Clinical Neurosciences 1996;8:270-5.
19. Frenchman IB, Prince T. Clinical experience with risperidone, haloperidol, and thioridazine for dementia-associated behavioral disturbances. International Psychogeriatrics 1997, 9:431-5.
20. Sultzer DL, Gray KF, Gunay I, Berisford A, Mahler ME. A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia. American Journal of Geriatric Psychiatry 1997;5:60-9.
21. Devanand DP, Marder K, Michaels KS et al. A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease. Am J Psychiatry 1998;155:1512-20.
22. Tariot PN, Erb R, Podgorski CA, Cox C, Patel S, Jakimovich L, Irvine C. Efficay and tolerability of carbamazepine for agitation and aggression in dementia. Am J Psychiatry 1998;155:54-61.
23. Christensen CB, Benfield WR. Alprazolam as an alternative to low-dose haloperidol in older, cognitively impaired nursing facility patients. J Am Geriatr Soc 1998;46:620-5.
24. Katona CLE, Hunter BN, Bray J. A double-blind comparison of the efficacy and safety of paroxetine and imipramine in the treatment of depression with dementia. Int J Ger Psych 1998;13:100-108
25. De Deyn PP, Rabheru K, Rasmussen A, Bocksberg JP, Dautzenberg PLJ, Eriksson S, Lawlor BA. A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia. Neurology 1999;53:946-55.
26. Katz IR, Jeste DV, Mintzer JE et al. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. J Clin Psychiatry 1999;60:107-15.
27. Street JS, Clark SC, Gannon KS et al. Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer's disease in nursing care facilities. A double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 2000;968-76.
28. Teri L, Logsdon RG, Peskind E et al. Treatment of agitation in AD. A randomized, placebo-controlled clinical trial. Neurology 2000;55:1271-8.
29. Allain H, Dautzenberg PLJ, Maurer K, Schuck S, Bonhomme D, Gérard D. Double blind study of tiapride versus haloperidol and placebo in agitation and aggressiveness in elderly patients with cognitive impairment. Psychopharmacology 2000;148:361-6.
30. Karlsson I, Godderis J, Mendonca Lima CA de, Nygaard H et al. A randomised, double-blind comparison of the efficacy and safety of citalopram compared to mianserin in elderly, depressed patients with or without mild to moderate dementia. Int J Geriat Psychiatry 2000;15:295-305.
31. Magai C, Kennedy G, Cohen C, Gomberg D. A controlled clinical trial of sertraline in the treatment of depression in nursing home patients with late-stage Alzheimer's disease. Am J Geriatr Psychiatry 2000;8:66-74.
32. McKeith I, Del Ser T, Spano P et al. Efficay of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet 2000;356:2031-6.
33. Sultzer DL, Gray KF, Gunay I, Wheatley MV, Mahler ME. Does behavioral improvement with haloperidol or trazodone treatment depend on psychosis or mood symptoms in patients with dementia? J Am Geriatr Soc 2001;49:1294-1300.
34. Götestam KG, Ljunghall S, Olsson B. A double-blind comparison of the effects of haloperidol anc cis(Z)-clopenthixol in senilde dementia. Acta Psychiatrica Scandinavica 1981;Supl 294,Vol 64:46-53.
35. Ather SA, Shaw SH, Stoker MJ. A comparison of chlormethiazole and thioridazine in agitated confusional states of the elderly. Acta Psychiatrica Scandinavica 1986;Supl 329,Vol 73:81-91.
36. Coccaro EF, Kramer E, Zemishlany Z et al. Pharmacologic treatment of noncognitive behavioral disturbances in elderly demented patients. Am J Psychiatry 1990;147:1640-5.
37. Schneider LS, Pollock VE, Lyness SA. A meta analysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc 1990;38:553-63.
38. Lanctôt KL, Best TS, Mittmann et al. Efficacy and safety of neuroleptics in behavioral disorders associated with dementia. J Clin Psychiatry 1998;59:550-61.
39. McShane R, Keene J, Gedling K, Fairburn C, Jacoby R, Hope T. Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow up. BMJ 1997;314:266-70.